Faculty

Institution

Unit

Venue

John M. Zajecka, MD

Professor

Rush University

Affiliations

Rush Medical College

Department Of Psychiatry And Behavioral Sciences

Rush University

John M. Zajecka, Md is currently serving as a Psychiatry And Behavioral Sciences Professor at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John M. Zajecka, MD

Rush University

Professor

You can click a keyword to filter the displayed items

psychiatry depression pharmacology clinical psychiatry mental health psychopharmacology psychopathology psychiatric research psychotropic medication medicine neuropharmacology pharmacotherapy neuropsychopharmacology affective disorders biological psychiatry translational psychiatry psychiatric disorders psychological medicine clinical trials psychology clinical psychology psychiatric care major depressive disorder mood symptom clinical research symptom management treatment-resistant depression psychiatric diseases neuropsychiatry molecular psychiatry psychoactive drugs anxiety disorders jama psychiatry sexual medicine psychoneuroendocrinology applied pharmacology sexual dysfunction cognitive therapy sexual psychophysiology relapse prevention subcortical ischemic depression bipolar disorder vagus nerve stimulation recurrent episodes behavioral disorders drug treatment comorbid psychiatric disorders randomized controlled trials brain stimulation clinical pharmacology clinical evidence therapy resistance treatment and prevention drug safety neuroendocrine disorders psychological co-morbidities cohort studies chronic depression esketamine nasal spray acute mania adjunctive therapy antidepressant medications discontinuation consensus panel hypothetical definition depressed patients major depressive disorders rush sexual inventory sexual function obesity medicine suicide psychiatric evaluations obesity management antiviral drugs antiviral therapy neurological progress patient-reported outcomes

Notable Scholarly Works

Notable Federal Grants

Collaborators

The Use of Vagus Nerve Stimulation (Vns) in the Management of Patients With Difficult-To-Treat Major Depressive Disorder (Mdd): An Expert Consensus Statement. Neuropsychiatric Disease and Treatment (2026)

mental healthneurologypsychiatryneuropsychiatrytranslational psychiatrypsychopharmacologypsychopathologydepression

Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine Er for Two Years (Prevent) Study. Psychopharmacology Bulletin (2025)

psychiatric diseasespsychiatrymood symptomvenlafaxine erpsychotropic medicationsymptom managementclinical trialsrecurrent episodesmedicinepharmacologyaffective disorderspsychopharmacologypharmacotherapydepressionsubcortical ischemic depression

Durability of the Benefit of Vagus Nerve Stimulation in Markedly Treatment-Resistant Major Depression: A Recover Trial Report. The International Journal of Neuropsychopharmacology (2025)

mental healthrecover trial reportvagus nerve stimulationpsychiatrymood symptomtreatment-resistant major depressionsymptom managementpsychological medicineclinical psychiatryrecoverypsychopathologydepressionrehabilitation

Efficacy and Tolerability of Esketamine Augmented With Dextromethorphan/Bupropion for Treatment-Resistant Depression. The Journal of Clinical Psychiatry (2025)

psychiatryneuropharmacologypsychotropic medicationapplied pharmacologyneuropsychopharmacologyclinical trialstreatment-resistant depressionmedicinepharmacologypsychopharmacologypharmacotherapypharmacological researchdepressionesketamine augmented

Esketamine Monotherapy in Adults With Treatment-Resistant Depression. JAMA Psychiatry (2025)

mental healthpsychiatric carepsychiatrypsychotropic medicationpsychiatric disordersjama psychiatrytherapeutic approachesmedicinepharmacologypsychopharmacologydepression

Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive Vns Therapy in Major Depressive Disorder. The Journal of Clinical Psychiatry (2025)

mental healthpsychiatric carepsychiatrymood symptomtreatment responsebiological psychiatrypsychotropic medicationpsychiatric disordersadjunctive vns therapyprescriptive predictorspsychological medicineclinical psychiatrytherapeutic approachesmedicineaffective disorderspsychopathologydepressionpsychology

Rapid Onset and Sustained Efficacy of Onfasprodil (Mij821), a Novel Nr2B Negative Allosteric Modulator, in Patients With Treatment-Resistant Depression. The Journal of Clinical Psychiatry (2025)

psychiatrybiological psychiatrypsychotropic medicationpsychiatric disordersmedicinepharmacologypsychopharmacologypharmacotherapymolecular psychiatrydepression

Clinical Characteristics and Treatment Exposure of Patients With Marked Treatment-Resistant Unipolar Major Depressive Disorder: A Recover Trial Report. Brain stimulation (2024)

Charles R. ConwayScott T. AaronsonHarold A. SackeimWalter DuffyMary StedmanJoão QuevedoRebecca M. AllenPatricio Riva-PosseMatthew A. BergerGustavo AlvaMohd Azfar MalikDavid L. DunnerIvan CichowiczHeather LuingJohn ZajeckaZiad NahasBrian J. MickeyAnita S. KablingerChristopher L. KriedtMark T. BunkerYing-Chieh (Lisa) LeeOlivia ShyShannon MajewskiBryan OlinQuyen TranA. John Rush

mental healthneurologypsychiatrytreatment exposureclinical psychiatryclinical characteristicsmedicinebrain stimulationdepression

Effects of Vagus Nerve Stimulation on Daily Function and Quality of Life in Markedly Treatment-Resistant Major Depression: Findings From a One-Year, Randomized, Sham-Controlled Trial. Brain stimulation (2024)

A John RushCharles R ConwayScott T AaronsonMark S GeorgePatricio Riva-PosseDavid L DunnerJohn ZajeckaMark T BunkerJoão QuevedoRebecca M AllenGustavo AlvaHeather LuingZiad NahasLucian ManuJeffrey I BennettBrian J MickeyJonathan BeckerYvette ShelineCristina CusinJames W MurroughKevin ReevesPeter B RosenquistYing-Chieh Lisa LeeShannon MajewskiJeffrey WayBryan OlinHarold A Sackeim

mental healththerapy resistancepsychiatrymood symptomneurostimulationtreatment-resistant major depressionsymptom managementvagus nerve stimulationquality of lifeneurosciencewell-beingneuropsychological rehabilitationdaily functionbrain stimulationaffective disorderssham-controlled trialdepressionrehabilitation

Evaluating an Eeg-Based Tool for Assessing Acute Clinical and Cognitive Changes in Adult Outpatients With Mdd Treated With Open-Label, Flexible-Dose Vortioxetine: A Pilot Study. Journal of Affective Disorders Reports (2024)

neurologypsychiatrybiological psychiatryneurophysiological biomarkerseeg-based toolneuroscienceneuropsychiatrycognitive impairmenttranslational psychiatryeeg signal processingcognitive changesflexible-dose vortioxetinepsychiatric researchneuropsychology

1
2
3
4
5
11
10 / page

John M. Zajecka, MD

Professor

Rush University

Affiliations

Rush Medical College

Department Of Psychiatry And Behavioral Sciences

Rush University

John M. Zajecka, Md is currently serving as a Psychiatry And Behavioral Sciences Professor at Rush University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

John M. Zajecka, MD

Rush University

Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

mental healthneurologypsychiatryneuropsychiatrytranslational psychiatrypsychopharmacologypsychopathologydepression

Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine Er for Two Years (Prevent) Study. Psychopharmacology Bulletin (2025)

Durability of the Benefit of Vagus Nerve Stimulation in Markedly Treatment-Resistant Major Depression: A Recover Trial Report. The International Journal of Neuropsychopharmacology (2025)

Efficacy and Tolerability of Esketamine Augmented With Dextromethorphan/Bupropion for Treatment-Resistant Depression. The Journal of Clinical Psychiatry (2025)

Esketamine Monotherapy in Adults With Treatment-Resistant Depression. JAMA Psychiatry (2025)

mental healthpsychiatric carepsychiatrypsychotropic medicationpsychiatric disordersjama psychiatrytherapeutic approachesmedicinepharmacologypsychopharmacologydepression

Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive Vns Therapy in Major Depressive Disorder. The Journal of Clinical Psychiatry (2025)

Rapid Onset and Sustained Efficacy of Onfasprodil (Mij821), a Novel Nr2B Negative Allosteric Modulator, in Patients With Treatment-Resistant Depression. The Journal of Clinical Psychiatry (2025)

psychiatrybiological psychiatrypsychotropic medicationpsychiatric disordersmedicinepharmacologypsychopharmacologypharmacotherapymolecular psychiatrydepression

Clinical Characteristics and Treatment Exposure of Patients With Marked Treatment-Resistant Unipolar Major Depressive Disorder: A Recover Trial Report. Brain stimulation (2024)

mental healthneurologypsychiatrytreatment exposureclinical psychiatryclinical characteristicsmedicinebrain stimulationdepression

1
2
3
4
5
11
10 / page